Answers are grounded in this paper and cite their sources.
Although there is a plethora of studies which examine the impact of the COVID-19 pandemic on India’s financial sector, we contribute by investigating the effect of the ongoing COVID-19 pandemic on stock returns of Indian pharmaceutical companies. By employing an event study methodology, our results indicate that the average returns of the pharmaceutical sector are positive during the COVID-19 phase although mixed evidence is found at the firm level. This finding is also robust to alternative model specifications.
No takes yet. Share an insight, caveat, or question.
Behera et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: